<?xml version="1.0" encoding="UTF-8"?>
<ref id="B136">
 <label>136</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Galuppo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Giacoppo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Iori</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>de Nicola</surname>
    <given-names>G. R.</given-names>
   </name>
   <name>
    <surname>Bramanti</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mazzon</surname>
    <given-names>E.</given-names>
   </name>
  </person-group>
  <article-title>Administration of 4-(
   <italic>Î±</italic>-L-Rhamnosyloxy)-benzyl isothiocyanate delays disease phenotype in SOD1G93ARats: a transgenic model of amyotrophic lateral sclerosis
  </article-title>
  <source>
   <italic toggle="yes">BioMed Research International</italic>
  </source>
  <year>2015</year>
  <volume>2015</volume>
  <fpage>12</fpage>
  <pub-id pub-id-type="publisher-id">259417</pub-id>
  <pub-id pub-id-type="doi">10.1155/2015/259417</pub-id>
  <pub-id pub-id-type="other">2-s2.0-84929643640</pub-id>
  <?supplied-pmid 26075221?>
  <pub-id pub-id-type="pmid">26075221</pub-id>
 </element-citation>
</ref>
